Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 11, 2022
Patent Application Number
15546259
Date Filed
January 26, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Embodiments of the disclosure encompass adoptive immunotherapy related to cells expressing multiple chimeric antigen receptors (CARs). In specific embodiments, T cells express a HER2-specific CAR, an IL13 Rα2-specific CAR, and an EphA2-specific CAR. In particular embodiments, the cells are utilized for cancer treatment, including for glioblastoma.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.